The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Open accessAbstract
Microdialysis in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D- and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter. However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and 5-HT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response. Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AMP increases the synaptic levels of monoamines (dopamine, noradrenaline and serotonin) by increasing their release through a reversal of the monoamine transporters, primarily the catecholamine transporters (see Fleckenstein et al., 2007; Hutson et al., 2014, for review; Kuczenski et al., 1995; Sulzer et al., 2005).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Kuczenski et al., 1995
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
Fischer, J. F., & Cho, A. K. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31549-1 · Cited by 443
Self-citationDetermination of Brain Interstitial Concentrations by Microdialysis
Benveniste, H., Hansen, A. J., & Ottosen, N. S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07252.x · Cited by 403
Kuczenski, R. T., & Segal, D. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Self-citationSulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Heikkila, R. E., Orlansky, H., Mytilineou, C., & Cohen, G. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30227-2 · Cited by 220
Berger, U. V., Gu, X. F., & Azmitia, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90023-w · Cited by 199
Segal, D. S., & Kuczenski, R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39192-5 · Cited by 177
Self-citationSampling considerations for on-line microbore liquid chromatography of brain dialysate
Wages, S. A., Church, W. H., & Justice, J. B. (1986) · Analytical Chemistry · doi:10.1021/ac00121a012 · Cited by 172
Globus, M. Y. ‐., Busto, R., Dietrich, W. D., Martinez, E., Valdés, I., & Ginsberg, M. D. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.123 · Cited by 165
Research works printed but not linked: 1
- Cole SO (1978) Brain mechanisms ofamohetamine-induced anorexia. locomdtion, And stereotypy: a review. fieurosci Biobehav Rev 2:891 100.
Cited by
Sorted by citations
Items 301–376 of 376
Lawrence, N., Sharp, T., Peters, S. P., Gray, J. A., & Young, A. M. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00552-9 · Cited by 5
Garcia-Munoz, M., Segal, D. S., Patino, P., Young, S. J., Kuczenski, R. T., & Groves, P. M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00161-8 · Cited by 5
Self-citationGéranton, S. M., Heal, D. J., & Stanford, S. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.012 · Cited by 5
Pharmacologic treatment for memory disorder in multiple sclerosis
He, D., Zhou, H., Guo, D., Hao, Z., & Wu, B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876 · Cited by 5
Miranda, F., Cedillo-Ildefonso, B., Jiménez, J. C., Bedolla-Núñez, G., & Torres-Rodríguez, S. (2011) · Revista Mexicana de Análisis de la Conducta · doi:10.5514/rmac.v37.i1.24685 · Cited by 5
Attention deficit hyperactivity disorder
Berridge, C. W., Devilbiss, D. M., Spencer, R. C., Schmeichel, B. E., & Arnsten, A. F. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.018 · Cited by 4
Jimenez, H. T., Carrión, J., Adrien, L. R., Wolin, A., Eun, J. D., Cinamon, E., Chang, E. H., Davies, P., Vo, A., & Koppel, J. L. (2023) · Biomedicines · doi:10.3390/biomedicines11082091 · Cited by 4
Lam, L., Anand, S., Li, X., Tse, M. L., Zhao, J. X., & Chan, E. W. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1529317 · Cited by 4
Dexamphetamine influences funneling illusion based on psychometric score
Kassim, F. M., Lim, J. H. M., Albrecht, M. A., & Martin-Iverson, M. T. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2862 · Cited by 4
Stimulants in Excessive Daytime Sleepiness
Sakai, N., Chikahisa, S., & Nishino, S. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.08.009 · Cited by 4
Yin, H., Cheng, P.-R., & Chen, C.-S. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.11.003 · Cited by 4
Dexmedetomidine to control signs associated with lisdexamfetamine dimesylate toxidrome in a cat.
Norkus, C. L., Keir, I., & Means, C. (2017) · PubMed Central · Cited by 4
Behavioral Pharmacology of Amphetamines
Rebec, G. V. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_32 · Cited by 4
Berridge, C. W., & Devilbiss, D. M. (2012) · Psiquiatría Biológica · doi:10.1016/j.psiq.2012.07.001 · Cited by 3
Rios, S. M., Mootz, J. R. K., Phillips, T. J., & Ingram, S. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02063-w · Cited by 3
Nishino, S., & Mignot, E. J.-M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00043-x · Cited by 3
Association Between Methamphetamine Versus Amphetamine and Acute Psychiatric Symptoms
Medhus, S., Holm, B., Mørland, J. G., & Bramness, J. G. (2013) · Journal of Dual Diagnosis · doi:10.1080/15504263.2013.835161 · Cited by 3
Lan, K., Liu, S., Lin‐Shiau, S., & Chang, A. (2015) · Journal of Medical Sciences · doi:10.4103/1011-4564.167740 · Cited by 3
Bauer, A. E., Jakobsdottir, M. R., & Ólafsdóttir, K. B. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae039 · Cited by 2
Quick, S. L., & Shahan, T. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000115 · Cited by 2
Hapten Design for Anti-addiction Vaccine Development
Collins, K. C., & Janda, K. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-23150-1_18 · Cited by 2
Bardo, M. T., Denehy, E. D., Hammerslag, L. R., Dwoskin, L. P., Blough, B. E., Landavazo, A., Bergman, J., & Kohut, S. J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05327-8 · Cited by 2
Reinforcing and Stimulant-Like Effects of Methamphetamine Isomers in Rhesus Macaques
Jacobs, D. S., Blough, B. E., & Kohut, S. J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000548 · Cited by 2
Nguyen, V., Harris, A. C., & Eltit, J. M. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.09.001 · Cited by 2
Pettie, M. A., Oakly, A., Harper, D. N., & Ellenbroek, B. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822156 · Cited by 2
A Chemical Perspective of Pharmacology and Toxicology
Cho, A. K. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053205 · Cited by 2
Self-citationNishino, S., & Mignot, E. J.-M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00044-x · Cited by 2
Shang, Q., Xiao, J., Gao, B., Liang, M., Wang, J., Qian, H., Xi, Z., Li, T., & Liu, X. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136102 · Cited by 2
Dexamphetamine widens temporal and spatial binding windows in healthy participants
Kassim, F. M., Krakonja, S., Keay, E. A., Iyyalol, R., Rodger, J., Albrecht, M. A., & Martin-Iverson, M. T. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220149 · Cited by 2
Dopamine and the use of SSRIs for conditions other than depression
Hale, A. S. (1996) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199606)11:2+ · Cited by 4
Attention-deficit hyperactivity disorder drug search trends: a Scandinavian perspective
Zoltek, M., & Ågren, R. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.20 · Cited by 1
Effects of methamphetamine on sexual behavior
Frohmader, K. S. (2011) · Scholarship@Western (Western University) · Cited by 1
The effects of naltrexone on neural responses to methamphetamine cues
Courtney, K. E., Ghahremani, D. G., & Ray, L. A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.141 · Cited by 1
Staley, J. K., & Cosgrove, K. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch6 · Cited by 1
Overview of Management of Narcolepsy
Nishino, S., & Kotorii, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-23739-8_21 · Cited by 1
Catecholamine influences on prefrontal cortex circuits and function
Arnsten, A. F. T., & Berridge, C. W. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.015 · Cited by 1
Analysis of D- and L- Isomers of (Meth)amphetamine in Human K2EDTA Plasma
Robbins, B., Perry, J., Long, M., & Carpenter, R. E. (2022) · Trends journal of sciences research · doi:10.31586/jbls.2023.534 · Cited by 1
Sakai, N., & Nishino, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378610-4.00126-1 · Cited by 1
Domínguez-López, S., Ahn, B., Sataranatarajan, K., Ranjit, R., Premkumar, P., Remmen, H. V., & Beckstead, M. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.12.507550 · Cited by 1
Hall, D. A. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Narcolepsy: Neuropharmacological Aspects
Nishino, S. (2007) · doi:10.1002/9780470101001.hcn048
Neuropharmacology of Attention‐Deficit/Hyperactivity Disorder
Glaser, P. E. A., Castellanos, F. X., & Margulies, D. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn056
(2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.567811
Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona
López‐Arnau, R. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Smittkamp, S. E., Spalding, H. N., Zhang, H., & Stanford, J. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3620-4
Yu, J., ALLISON, S., IBRAHIM, D., Cadet, J. L., & Angulo, J. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04166.x
Balducci, X. L. (2009) · TSpace (University of Toronto)
Joyce, B. M. (2006) · UKnowledge (University of Kentucky)
Baker, T. W. (2013) · QSpace (Queen's University Library)
Do Central Nervous System Stimulants Lower Seizure Threshold?
Sheth, R. D., & Samaniego, E. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374006-9.00018-7
Akingbola, O., & Singh, D. (2012)
The pathogenesis of narcolepsy, current treatments and prospective therapeutic targets
Maruyama, T., Matsumura, M., Sakai, N., & Nishino, S. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1117973
Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses
Gomes, A. T. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/wbf2-1943
Pharmacological Characterization of an Optimized Sigma Receptor Ligand
Seminerio, M. J. (2012) · doi:10.33915/etd.3561
Ramkissoon, A. (2012) · TSpace (University of Toronto)
Anneken, J. H., Collins, S. A., Yamamoto, B. K., & Gudelsky, G. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00038-8
Chau, S. A. (2013) · TSpace (University of Toronto)
Animal Models of Addiction other than Alcohol
Häggkvist, J., & Franck, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398335-0.00007-8
Sakai, N., & Nishino, S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10006-4
Clauss, N. J., & Daws, L. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00172-9
Cezar, L. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2022.tde-20012023-112002
Lafuente, J. V., Sharma, A., Feng, L., Muresanu, D. F., Nozari, A., Tian, Z. R., Buzoianu, A. D., Sjöquist, P.-O. B., Wiklund, L., & Sharma, H. S. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_8
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Drug Target Insights · doi:10.33393/dti.2006.1296
Elder, H. J., Walentiny, D. M., & Beardsley, P. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4658637
The Role of Dopamine in Resistance to Change of Operant Behavior
Quick, S. L. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/64c5-a6f4
Kohe, S. E., Gowing, E. K., Seo, S., Grattan, D. R., Kokay, I. C., Zheng, Y., Liu, P., & Oorschot, D. E. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107573
Methamphetamine-induced disruption of neuropeptide expression in mice
Pathikkaran, N. A., Böröczky, C., Redl, B., Papageorgiou, K., Hökfelt, T., Harkany, T., & Hevesi, Z. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102664
Lapa, J. F. R. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Gabab Regulation of Methamphetamine-Induced Associative Learning
Voigt, R. M. (2010) · Loyola eCommons (Loyola University of Chicago)
- Self-citation
Sandman (1999) · doi:10.1002/(sici)1098-2302(199904)34:3
Metadata
- Authors
- Kuczenski, R., Segal, D., Cho, A., & Melega, W.
- Affiliations
- UC San Diego Health System (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1995-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 1308-1317
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6577819
- OpenAlex
- W1934404972
- Cited by
- 376
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 24 · 2013: 18 · 2012: 22
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da002411-13, 5r01da004157-14)
- U.S. Public Health Service
- National Institute on Drug Abuse (DA-01568, DA 02411, DA04157, R01DA001568)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, d-amphetamine, stereotypy, dopamine release, noradrenaline release, serotonin release, caudate nucleus, hippocampus, vesicular transporters, structure-activity relationship, microdialysis
- MeSH terms
- Amphetamine, Animals, Behavior, Animal, Caudate Nucleus, Dopamine, Hippocampus, Methamphetamine, Norepinephrine, Serotonin, Stereoisomerism, Stereotyped Behavior, Microdialysis, Neurotransmitter Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
